ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for NASDAQ stock FATE Fate Therapeutics. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 2.13 and Closed at: 2.08, which is -4.33% of previous session's close. It moved within a range of 2.01 and 2.16
The session was a Bearish session with an average volume of 1064400, which is 24.45% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 1.97 and resistance for tomorrow is 2.12
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.01, 1.93 resistance for tomorrow's hourly charts is 2.16, 2.23

10 Day SMA for Fate Therapeutics (FATE) is 2.08 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Fate Therapeutics (FATE) is 2.09 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Fate Therapeutics (FATE) is 2.29 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.42 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Fate Therapeutics is 1.97 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Fate Therapeutics is at 2.09 and 200 DMA is at 1.97, while 50 DMA and 100 DMA are at 2.29 and 2.42 respectively

Fate Therapeutics (FATE) moving average of 20 SMA is at 2.09 and 20 EMA is at 2.12

Fate Therapeutics (FATE) moving average of 50 SMA is at 2.29 and 50 EMA is at 2.22

Fate Therapeutics (FATE) moving average of 100 SMA is at 2.42 and 100 EMA is at 2.25

Fate Therapeutics (FATE) moving average of 200 SMA is at 1.97 and 200 EMA is at 2.02

111 Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in 111 Inc, about 4.88% more returns!

Veru Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Veru Inc, about 0.28% more returns!

Summit Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Summit Therapeutics, about 7.11% more returns!

Omeros Corporation has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 11.97% more returns!

Fate Therapeutics has performed better than Aldeyra Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

Amgen Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 30.01% more returns!

Amphastar Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 23.66% more returns!

Fate Therapeutics has performed better than Aptevo Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

Apyx Medical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 14.4% more returns!

Arrowhead Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 10.47% more returns!

Diamedica Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 24.26% more returns!

Guardant Health has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 9.85% more returns!

Hutchison China has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Hutchison China, about 6.29% more returns!

Fate Therapeutics has performed better than Iovance Biotherapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

Kamada has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Kamada, about 10.65% more returns!

Fate Therapeutics Technical analysis of indicators

Price action analysis of Fate Therapeutics (FATE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Fate Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Fate Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Fate Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.06 and Fate Therapeutics FATE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

Fate Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And FATE Experts View which covers a lot of information including buying and selling signals

FATE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

Chart Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

 

Back to top